Cel Sci (CVM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.74, +1.75% vs the prior close of $1.71.
- Volume 72.00K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CVM rises 1.8% to $1.74. Closed at $1.74, +1.75% vs the prior close of $1.71. Day range $1.66–$1.78, opened at $1.69.
CVM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CVM rises 1.8% to $1.74
- Closed at $1.74, +1.75% vs the prior close of $1.71. Day range $1.66–$1.78, opened at $1.69.
- Volume was 72.00K shares, 0.3x its 50-day average of 211.35K — lighter than usual.
- Price is +2.7% vs its 50-day average ($1.69) and -36.3% vs its 200-day average ($2.73).
- 52-week range $0.89–$10.24; today's close sits at 9% of that range, 83.0% below the 52-week high.
Oct 14, 2026 — CVM dips 2.3% to $1.71, 6 down days in a row
- Closed at $1.71, -2.29% vs the prior close of $1.75. Day range $1.68–$1.75, opened at $1.73.
- Volume was 105.70K shares, 0.5x its 50-day average of 214.63K — lighter than usual.
- Price is +1.2% vs its 50-day average ($1.69) and -37.8% vs its 200-day average ($2.75).
- 52-week range $0.89–$10.24; today's close sits at 9% of that range, 83.3% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — CVM slides 4.4% to $1.75, 5 down days in a row
- Closed at $1.75, -4.37% vs the prior close of $1.83. Day range $1.71–$1.84, opened at $1.84.
- Volume was 224.60K shares, 1.0x its 50-day average of 223.51K.
- Price is +4.0% vs its 50-day average ($1.68) and -36.6% vs its 200-day average ($2.76).
- 52-week range $0.89–$10.24; today's close sits at 9% of that range, 82.9% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — CVM slides 5.7% to $1.83, 4 down days in a row
- Closed at $1.83, -5.67% vs the prior close of $1.94. Day range $1.76–$1.97, opened at $1.95.
- Volume was 357.20K shares, 1.6x its 50-day average of 219.68K.
- Price is +9.4% vs its 50-day average ($1.67) and -34.1% vs its 200-day average ($2.78).
- 52-week range $0.89–$10.24; today's close sits at 10% of that range, 82.1% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — CVM dips 0.5% to $1.94, 3 down days in a row
- Closed at $1.94, -0.51% vs the prior close of $1.95. Day range $1.83–$1.98, opened at $1.96.
- Volume was 255.40K shares, 1.2x its 50-day average of 217.14K.
- Price is +16.9% vs its 50-day average ($1.66) and -30.5% vs its 200-day average ($2.79).
- 52-week range $0.89–$10.39; today's close sits at 11% of that range, 81.3% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — CVM slides 8.5% to $1.95 on 1.8x normal volume
- Closed at $1.95, -8.45% vs the prior close of $2.13. Day range $1.92–$2.25, opened at $2.10.
- Volume was 385.50K shares, 1.8x its 50-day average of 212.46K — unusually heavy trading.
- Price is +18.6% vs its 50-day average ($1.64) and -30.4% vs its 200-day average ($2.80).
- 52-week range $0.89–$10.62; today's close sits at 11% of that range, 81.6% below the 52-week high.
Oct 7, 2026 — CVM slides 22.3% to $2.13 on 3.3x normal volume
- Closed at $2.13, -22.26% vs the prior close of $2.74. Day range $2.07–$2.77, opened at $2.74.
- Volume was 661.10K shares, 3.3x its 50-day average of 202.12K — unusually heavy trading.
- Price is +30.8% vs its 50-day average ($1.63) and -24.4% vs its 200-day average ($2.82).
- 52-week range $0.89–$10.62; today's close sits at 13% of that range, 79.9% below the 52-week high.
Oct 6, 2026 — CVM jumps 13.2% to $2.74, a 3-month high on 2.4x normal volume
- Closed at $2.74, +13.22% vs the prior close of $2.42. Day range $2.29–$2.83, opened at $2.42.
- Volume was 470.10K shares, 2.4x its 50-day average of 195.69K — unusually heavy trading.
- Price is +70.2% vs its 50-day average ($1.61) and -3.3% vs its 200-day average ($2.83).
- 52-week range $0.89–$10.70; today's close sits at 19% of that range, 74.4% below the 52-week high.
- That makes 7 straight gains.
Oct 5, 2026 — CVM jumps 4.8% to $2.42, a 3-month high on 4.4x normal volume
- Closed at $2.42, +4.76% vs the prior close of $2.31. Day range $2.35–$2.75, opened at $2.39.
- Volume was 796.10K shares, 4.4x its 50-day average of 182.67K — unusually heavy trading.
- Price is +53.3% vs its 50-day average ($1.58) and -15.1% vs its 200-day average ($2.85).
- 52-week range $0.89–$10.83; today's close sits at 15% of that range, 77.7% below the 52-week high.
- That makes 6 straight gains.
Oct 2, 2026 — CVM jumps 10.5% to $2.31, a 3-month high on 2.2x normal volume
- Closed at $2.31, +10.53% vs the prior close of $2.09. Day range $2.03–$2.31, opened at $2.14.
- Volume was 387.50K shares, 2.2x its 50-day average of 177.05K — unusually heavy trading.
- Price is +48.7% vs its 50-day average ($1.55) and -19.4% vs its 200-day average ($2.87).
- 52-week range $0.89–$10.83; today's close sits at 14% of that range, 78.7% below the 52-week high.
- That makes 5 straight gains.
CVM latest news & SEC filings
Every SEC filing by or about CVM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Talor Eyal received an award of 1,165 shares at $2.06 (≈$2.40K) on Sep 30, 2026; now holds 10,483
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Prichep Patricia B received an award of 2,082 shares at $2.06 (≈$4.29K) on Sep 30, 2026; now holds 19,571
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kersten Geert R received an award of 2,621 shares at $2.06 (≈$5.40K) on Sep 30, 2026; now holds 318,763
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kersten Geert R bought 100,000 shares at $1.38 (≈$138.00K) on Aug 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.67M (prior year -$5.66M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.47 (prior year -$1.36) (loss narrowed vs Jun 30, 2025)
Jul 2, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Jul 2, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade CVM
- How much it moves: over the last 20 sessions the average daily move was 5.89% (largest 22.3%). That is a volatile stock.
- Liquidity: about 298.49K shares (≈$519.37K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.74 vs a range of $0.89–$10.24 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on May 20, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 0 sales; latest: Geert R Kersten bought 100,000 shares on Aug 25, 2026.
- Latest filings: 8-K Aug 17, 2026; 10-Q Aug 14, 2026; 8-K Jun 16, 2026.
- Share count: 17.59M shares outstanding (Aug 10, 2026), +155.6% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Biological Products, (No Diagnostic Substances).
CVM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.69 | 1.78 | 1.66 | 1.74 | 72.00K |
| Oct 14, 2026 | 1.73 | 1.75 | 1.68 | 1.71 | 105.70K |
| Oct 13, 2026 | 1.84 | 1.84 | 1.71 | 1.75 | 224.60K |
| Oct 12, 2026 | 1.95 | 1.97 | 1.76 | 1.83 | 357.20K |
| Oct 9, 2026 | 1.96 | 1.98 | 1.83 | 1.94 | 255.40K |
| Oct 8, 2026 | 2.10 | 2.25 | 1.92 | 1.95 | 385.50K |
| Oct 7, 2026 | 2.74 | 2.77 | 2.07 | 2.13 | 661.10K |
| Oct 6, 2026 | 2.42 | 2.83 | 2.29 | 2.74 | 470.10K |
| Oct 5, 2026 | 2.39 | 2.75 | 2.35 | 2.42 | 796.10K |
| Oct 2, 2026 | 2.14 | 2.31 | 2.03 | 2.31 | 387.50K |
| Oct 1, 2026 | 2.06 | 2.30 | 1.96 | 2.09 | 807.60K |
| Sep 30, 2026 | 1.80 | 2.09 | 1.78 | 2.06 | 474.00K |
| Sep 29, 2026 | 1.70 | 1.79 | 1.70 | 1.79 | 74.50K |
| Sep 28, 2026 | 1.67 | 1.72 | 1.67 | 1.70 | 126.20K |
| Sep 25, 2026 | 1.70 | 1.71 | 1.67 | 1.67 | 36.40K |
| Sep 24, 2026 | 1.70 | 1.76 | 1.68 | 1.72 | 56.10K |
| Sep 23, 2026 | 1.69 | 1.76 | 1.68 | 1.68 | 171.40K |
| Sep 22, 2026 | 1.70 | 1.73 | 1.66 | 1.70 | 133.80K |
| Sep 21, 2026 | 1.71 | 1.75 | 1.66 | 1.67 | 109.60K |
| Sep 18, 2026 | 1.53 | 1.70 | 1.51 | 1.66 | 265.00K |
About Cel Sci
Cel Sci (CVM) is listed on the NYSE and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in VIENNA, VA. State of incorporation: CO. Fiscal year ends September 30. SEC CIK 725363.
CVM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Bruno Jean-Marie Baillavoine | Director | Aug 17, 2026 |
| Geert R Kersten | Chief Executive Officer | Aug 26, 2026 |
| Robert Eugene Watson | Director | Aug 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Cipriano | Senior Vice President | Aug 17, 2026 |
| Geert R Kersten | Chief Executive Officer | Aug 26, 2026 |
| Patricia B Prichep | Chief Financial Officer | Aug 17, 2026 |
| Eyal Talor | Chief Scientific Officer | Aug 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Geert R Kersten | Buy | 100,000 | $1.38 |
| May 14, 2026 | Geert R Kersten | Buy | 300,000 | $1.20 |
| May 13, 2026 | Geert R Kersten | Buy | 100,000 | $1.19 |
| Jan 22, 2026 | Geert R Kersten | Buy | 38,023 | $5.26 |
| Dec 4, 2025 | Geert R Kersten | Buy | 8,389 | $5.96 |
CVM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $-25.41M | -6.27 | $-17.12M |
| Sep 30, 2024 | — | $-26.92M | -15.31 | $-18.81M |
| Sep 30, 2023 | — | $-32.37M | -0.73 | $-22.85M |
| Sep 30, 2022 | — | $-36.70M | -0.87 | $-18.24M |
| Sep 30, 2021 | — | $-36.36M | -0.90 | $-18.79M |
Latest balance sheet: total assets $21.36M, total liabilities $10.40M, cash $5.14M (as of Jun 30, 2026).
CVM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CVM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.